Who has invested in Expedition Therapeutics?

Venrock, BVF Partners, Lake Bleu Capital, Sofinnova Investments, Novo Holdings, Forbion are named among the investors backing Expedition Therapeutics.

Expedition Therapeutics Funding: $165M Raised, Series A

Expedition Therapeutics funding overview

Expedition Therapeutics is a Biotech company based in San Francisco. Expedition Therapeutics has raised $165M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2025. The round record for Expedition Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Venrock, BVF Partners, Lake Bleu Capital, Sofinnova Investments, Novo Holdings, Forbion and 3 others. 9 distinct backers are named across the disclosed rounds.

Expedition Therapeutics at a glance

Total raised: $165M
Latest round: Series A
Latest round date: October 2025
Industry: Biotech
Headquarters: San Francisco
Notable investors: Venrock, BVF Partners, Lake Bleu Capital, Sofinnova Investments, Novo Holdings, Forbion, Dawn Biopharma, Adage Capital

Frequently asked about Expedition Therapeutics funding

How much has Expedition Therapeutics raised?: Expedition Therapeutics has raised $165M in total disclosed funding across the rounds on record.
Who has invested in Expedition Therapeutics?: Venrock, BVF Partners, Lake Bleu Capital, Sofinnova Investments, Novo Holdings, Forbion are named among the investors backing Expedition Therapeutics.
What was the latest Expedition Therapeutics funding round?: The most recent disclosed round is a Series A, announced in October 2025.
Where is Expedition Therapeutics based?: Expedition Therapeutics is based in San Francisco.
What sector does Expedition Therapeutics operate in?: Expedition Therapeutics is tracked under Biotech from San Francisco, with $165M in disclosed funding.
When did Expedition Therapeutics last raise?: The last disclosed Expedition Therapeutics round closed in October 2025 at Series A.

Expedition Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Francisco below to benchmark round size and investor mix.

Expedition Therapeutics Funding: $165M Raised, Series A

Expedition Therapeutics funding overview

Expedition Therapeutics at a glance

Frequently asked about Expedition Therapeutics funding

Expedition Therapeutics founders (1)

Companies related to Expedition Therapeutics (40)

Browse related funding lists (11)